---
title: "Novo Nordisk's stock price fell by 2.3%, with the decline widening after its bid to acquire Medtroni"
description: "Novo Nordisk's stock price fell by 2.3%, with the decline widening after its bid to acquire Medtronic was announced"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/263484695.md"
published_at: "2025-10-30T10:20:47.000Z"
---

# Novo Nordisk's stock price fell by 2.3%, with the decline widening after its bid to acquire Medtroni

> Novo Nordisk's stock price fell by 2.3%, with the decline widening after its bid to acquire Medtronic was announced

Novo Nordisk's stock price fell by 2.3%, with the decline widening after its bid to acquire Medtronic was announced

### Related Stocks

- [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| GLP-1 Anti-Obesity U.S. Drug Market In Four Charts | UBS analysts, led by Matthew Weston, have analyzed trends in the U.S. GLP-1 anti-obesity drug market, focusing on new-to | [Link](https://longbridge.com/en/news/276280378.md) |
| Novo Nordisk A/S - share repurchase programme | Novo Nordisk A/S has initiated a share repurchase programme of up to DKK 15 billion, starting from 4 February 2026. As o | [Link](https://longbridge.com/en/news/276056741.md) |
| Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total  | [Link](https://longbridge.com/en/news/275761183.md) |
| Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/en/news/275789396.md) |
| Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/en/news/275652909.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.